How to buy Merrimack Pharmaceuticals stock (MACK)

Merrimack Pharmaceuticals is a biotechnology business based in the US. Merrimack Pharmaceuticals shares (MACK) are listed on the NASDAQ and all prices are listed in US Dollars.

Our top picks for where to buy Merrimack Pharmaceuticals stock

Buy Merrimack Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Merrimack Pharmaceuticals stock price (NASDAQ: MACK)

Use our graph to track the performance of MACK stocks over time.

Merrimack Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-07-21.

52-week range	$12.94 - $15.89
50-day moving average more info button	$14.84
200-day moving average more info button	$13.48
Wall St. target price	$4.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.09

Is it a good time to buy Merrimack Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Merrimack Pharmaceuticals stock undervalued or overvalued?

Valuing Merrimack Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merrimack Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Merrimack Pharmaceuticals's PEG ratio

Merrimack Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merrimack Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Merrimack Pharmaceuticals financials

Gross profit TTM	$-9,100,000
Return on assets TTM	-1.07%
Return on equity TTM	-1.12%
Profit margin	0%
Book value	$15.25
Market Capitalization more info button	$223.7 million

TTM: trailing 12 months

Merrimack Pharmaceuticals share dividends

We're not expecting Merrimack Pharmaceuticals to pay a dividend over the next 12 months.

Have Merrimack Pharmaceuticals's shares ever split?

Merrimack Pharmaceuticals's shares were split on a 1:10 basis on 5 September 2017 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Merrimack Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Merrimack Pharmaceuticals shares which in turn could have impacted Merrimack Pharmaceuticals's share price.

Merrimack Pharmaceuticals share price volatility

Over the last 12 months, Merrimack Pharmaceuticals's shares have ranged in value from as little as $12.94 up to $15.89. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Merrimack Pharmaceuticals's is 1.416. This would suggest that Merrimack Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Merrimack Pharmaceuticals overview

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. .

Frequently asked questions

What percentage of Merrimack Pharmaceuticals is owned by insiders or institutions?
Currently 1.191% of Merrimack Pharmaceuticals shares are held by insiders and 62.978% by institutions. When does the fiscal year end for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals's fiscal year ends in December. Where is Merrimack Pharmaceuticals based?
Merrimack Pharmaceuticals's address is: One Broadway, Cambridge, MA, United States, 02142 What is Merrimack Pharmaceuticals's ISIN number?
Merrimack Pharmaceuticals's international securities identification number is: US5903282094 What is Merrimack Pharmaceuticals's CUSIP number?
Merrimack Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 590328209